Back
Franklin International Core Dividend Tilt Idx ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
70
DIVI
Franklin International Core Dividend Tilt Idx ETF
Last Price:
$38.58
Seasonality Move:
2.51%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Buy
70
Franklin International Core Dividend Tilt Idx ETF (DIVI)
is a Buy
Is Franklin International Core Dividend Tilt Idx ETF a Buy, Sell or Hold?
-
The current Franklin International Core Dividend Tilt Idx ETF [DIVI] share price is $38.60. The Score for DIVI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
DIVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DIVI Stock Price Chart
What is Franklin International Core Dividend Tilt Idx ETF's stock price today?
-
The Franklin International Core Dividend Tilt Idx ETF share price today is $38.60The current trend is moderately bearish and DIVI is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $68.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
DIVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 51.93 | Buy |
| Chaikin Money Flow: | -19160 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.69 - 38.97) | Buy |
| Bollinger Bands (100): | (36.63 - 38.39) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.61 | Sell |
| Relative Strength Index (14 RSI): | 37.25 | Sell |
| Chaikin Money Flow: | 166161 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.18 - 85.74) | Sell |
| Bollinger Bands (100): | (45.57 - 89.21) | Buy |
DIVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.98 | Sell |
| 20-day SMA: | 38.53 | Buy |
| 50-day SMA: | 38.11 | Buy |
| 200-day SMA: | 35.87 | Buy |
| 8-day EMA: | 38.83 | Sell |
| 20-day EMA: | 38.6 | Sell |
| 50-day EMA: | 38.15 | Buy |
| 200-day EMA: | 36.15 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.35 | Sell |
| 20-day SMA: | 78.65 | Sell |
| 50-day SMA: | 81.47 | Sell |
| 200-day SMA: | 52.32 | Buy |
| 8-day EMA: | 71.44 | Sell |
| 20-day EMA: | 75.9 | Sell |
| 50-day EMA: | 76.79 | Sell |
| 200-day EMA: | 56.68 | Buy |
Franklin International Core Dividend Tilt Idx ETF Earnings Growth & DIVI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Franklin International Core Dividend Tilt Idx ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||